1. Home
  2. XERS vs VRTS Comparison

XERS vs VRTS Comparison

Compare XERS & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • VRTS
  • Stock Information
  • Founded
  • XERS 2005
  • VRTS 1988
  • Country
  • XERS United States
  • VRTS United States
  • Employees
  • XERS N/A
  • VRTS N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • VRTS Investment Managers
  • Sector
  • XERS Health Care
  • VRTS Finance
  • Exchange
  • XERS Nasdaq
  • VRTS Nasdaq
  • Market Cap
  • XERS 1.3B
  • VRTS 1.3B
  • IPO Year
  • XERS 2018
  • VRTS 1992
  • Fundamental
  • Price
  • XERS $8.33
  • VRTS $191.60
  • Analyst Decision
  • XERS Strong Buy
  • VRTS Hold
  • Analyst Count
  • XERS 7
  • VRTS 4
  • Target Price
  • XERS $8.00
  • VRTS $190.50
  • AVG Volume (30 Days)
  • XERS 2.1M
  • VRTS 85.4K
  • Earning Date
  • XERS 11-07-2025
  • VRTS 10-24-2025
  • Dividend Yield
  • XERS N/A
  • VRTS 4.70%
  • EPS Growth
  • XERS N/A
  • VRTS 37.35
  • EPS
  • XERS N/A
  • VRTS 20.53
  • Revenue
  • XERS $246,025,000.00
  • VRTS $888,980,000.00
  • Revenue This Year
  • XERS $43.89
  • VRTS N/A
  • Revenue Next Year
  • XERS $20.40
  • VRTS $1.36
  • P/E Ratio
  • XERS N/A
  • VRTS $9.33
  • Revenue Growth
  • XERS 35.62
  • VRTS 0.99
  • 52 Week Low
  • XERS $2.73
  • VRTS $142.18
  • 52 Week High
  • XERS $8.51
  • VRTS $252.82
  • Technical
  • Relative Strength Index (RSI)
  • XERS 61.63
  • VRTS 48.11
  • Support Level
  • XERS $7.88
  • VRTS $184.70
  • Resistance Level
  • XERS $8.51
  • VRTS $195.00
  • Average True Range (ATR)
  • XERS 0.37
  • VRTS 4.11
  • MACD
  • XERS -0.01
  • VRTS 0.05
  • Stochastic Oscillator
  • XERS 83.05
  • VRTS 60.00

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

Share on Social Networks: